BiotechTube
Home/Pipeline/Sarclisa (Isatuximab) SC

Sarclisa (Isatuximab) SC

Multiple Myeloma

Regulatory (EU)ActiveN/A

Key Facts

Indication
Multiple Myeloma
Phase
Regulatory (EU)
Status
Active
Company
Sanofi

About Sanofi

Sanofi is a global biopharmaceutical leader with a mission to 'chase the miracles of science' by developing innovative medicines and vaccines. The company has strategically pivoted to become an R&D-driven, AI-powered organization, focusing its deep immunoscience expertise on high-growth areas like immunology and oncology. Its strategy is centered on accelerating drug discovery, optimizing its robust pipeline, and delivering compelling growth through breakthrough therapeutics.

View full company profile

Therapeutic Areas

ImmunologyOncologyRare DiseasesNeurologyVaccines

Other Multiple Myeloma Drugs

DrugCompanyPhase
TasquinimodActive BiotechPreclinical
Measovir®-based candidateOncovitaPre-clinical
Kyprolis® (carfilzomib)Cleo Life SciencesApproved
inobrodib (CCS1477)CellCentricPhase 1/2
ISB 2001Ichnos Glenmark InnovationPhase 1b
In Vivo Cell TherapyGigaMunePre-clinical
HemadyDexcel Pharma USAApproved
AV-353AVEO OncologyPre-clinical
Sequesta™ID4PharmaPre-clinical
Myeloma ConsortiumCriteriumUnknown
GPRC5D x CD3 TCEIntegral MolecularPreclinical
RORA-Tscm CAR-TRORABioPre-clinical